Our previous study demonstrated the inhibition of HDAC4 either genetically by shRNA or pharmaceutically by an HDACi (panobinostat) combined with RT to reduce proliferation of HCC cells and growth of ectopic xenografts via specific DNA repair pathway (14). This evidence concerns the gene HDAC4 and hepatocellular carcinoma.